<i>SHLD2</i> loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy. [PDF]
Rodriguez-Berriguete G +26 more
europepmc +1 more source
Loss of MSH6 or MSH2 sensitizes progressive glioblastoma to radiotherapy. [PDF]
Moisoiu V +15 more
europepmc +1 more source
Targeting glutathione metabolism for tumor radiosensitization (Review). [PDF]
Xu H, Du M, Liang X, Xiao X, Chen Z.
europepmc +1 more source
Induction of transferrin receptor 1-mediated ferroptosis by ultrasound-triggered microbubble destruction sensitizes glioblastoma to radiotherapy. [PDF]
He Y +16 more
europepmc +1 more source
pH responsive nanoplatforms for radiosensitization and radioprotection in cancer therapy. [PDF]
Dai E, Qiu Y, Xu H, Zhong G, Feng W.
europepmc +1 more source
Nanoparticle-Based Radiosensitization in Breast Cancer: A Multimodal Approach to Therapy and Immune Regulation. [PDF]
AlAbdulhadi SAS +9 more
europepmc +1 more source
Synergistic Effects of Arsenite on Radiosensitization of Glioblastoma Cells
BACKGROUND/AIM: Glioblastoma is a frequent type of brain tumor and is radioresistant. Arsenite, which crosses the blood-brain barrier, shows synergistic effects with radiation in vitro and in vivo. The mechanism remains unclear. MATERIALS AND METHODS: As
二宮, 康晴 +15 more
core
Beyond apoptosis: nanomedicine enabled reprogramming of tumor cell death for next-generation radiosensitization. [PDF]
Ye X +7 more
europepmc +1 more source
Natural phenolic compounds as modulators of radiation response in hepatocellular carcinoma. [PDF]
Imani A, Rassouli FB.
europepmc +1 more source
Hypoxia-Targeting Strategies in Radiotherapy and Nitroimidazole-Based Radiosensitizers: A Narrative Review and Translational Perspectives. [PDF]
Rosa E +9 more
europepmc +1 more source

